Net Loss Per Share (Tables)

12 Months Ended

Dec. 31, 2023

Income Statement [Abstract]

Schedule of Anti-dilutive Securities Excluded from Computation of Diluted Net Loss Per Share

The following common stock equivalents were excluded from the computation of diluted net loss per share for the periods presented because including them would have had an anti-dilutive effect:

	December 31,
	2023		2022
Employee stock options and RSUs issued and outstanding		15,829,198		9,637,022
Series A Common Stock Equivalent Convertible Preferred Stock		2,500,000		2,500,000
Common stock subject to the Company’s repurchase right		34,384		526,660
Total		18,363,582		12,663,682